MAPT and Alzheimer disease: The average CSF tau levels and average tau/Aβ 1–42 ratio in AD were significantly higher than in controls and DLB (tau, p = .001 and p = .001; tau/Aβ 1–42 ratio, p = .009 and p = .007) (Fig 2C and 2D).